Proliferating cell nuclear antigen (PCNA) overexpression in hepatocellular carcinoma predicts poor prognosis as determined by bioinformatic analysis.

Author: Dan-Dan LI ^{1
,

2} ; Jia-Wei ZHANG ^{1
,

2} ; Rui ZHANG ^{1
,

2} ; Jie-Hong XIE ^{1
,

2} ; Kuo ZHANG ^{1
,

2} ; Gui-Gao LIN ^{1
,

2} ; Yan-Xi HAN ^{1
,

2} ; Rong-Xue PENG ^{1
,

2} ; Dong-Sheng HAN ^{1
,

2} ; Jie WANG ^{1
,

2} ; Jing YANG ^{1
,

2} ; Jin-Ming LI ^{1
,

2}
Author Information

1. National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology
2. Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing 100005, China.
Publication Type:Journal Article
MeSH: Carcinoma, Hepatocellular/genetics*; Computational Biology; Humans; Liver Neoplasms/genetics*; Prognosis; Proliferating Cell Nuclear Antigen
From: Chinese Medical Journal 2020;134(7):848-850
CountryChina
Language:English